SCHEMBL24198524

SCHEMBL24198524

CCc1nc2ccc(COC)c(F)c2[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
TYMS P04818 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34
PDE10A Q9Y233 1/20 0.34
PARP1 P09874 2/20 0.33
PARP2 Q9UGN5 2/20 0.33
ALDH1A1 P00352 5/20 0.32
EGFR P00533 2/20 0.32
HSD17B10 Q99714 4/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CRHR1 P34998 1/20 0.31
LMNA P02545 2/20 0.31
PKM P14618 1/20 0.31
MAPK1 P28482 1/20 0.31
DAO P14920 1/20 0.31
PSMB5 P28074 1/20 0.31
TNKS O95271 1/20 0.31
PARP6 Q2NL67 1/20 0.31
PARP3 Q9Y6F1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24156575 0.84 KDM4E (0.46) KDM4ETYMSPARP1PARP2ALDH1A1
SCHEMBL30212555 0.84 KDM4E (0.46) KDM4ETYMSPARP1PARP2ALDH1A1
SCHEMBL30212546 0.84 KDM4E (0.46) KDM4ETYMSHCAR2PARP1PARP2
SCHEMBL24157228 0.84 KDM4E (0.46) KDM4ETYMSHCAR2PARP1PARP2
SCHEMBL24157226 0.78 KDM4E (0.48) KDM4EPARP1PARP2ALDH1A1HSD17B10
SCHEMBL30297076 0.78 KDM4E (0.48) KDM4EPARP1PARP2ALDH1A1HSD17B10
SCHEMBL24157278 0.78 KDM4E (0.48) KDM4ETYMSPARP1PARP2ALDH1A1
SCHEMBL30297085 0.78 KDM4E (0.48) KDM4ETYMSPARP1PARP2ALDH1A1
SCHEMBL30212587 0.76 PARP1 (0.46) KDM4EPARP1PARP2LMNATNKS
SCHEMBL31097523 0.75 KDM4E (0.44) KDM4EPARP1PARP2ALDH1A1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795158-B2 Chemical compounds ASTRAZENECA AB (SE) 2023-10-24 US disclosed
US-20220009901-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2022-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11795158-B2 Chemical compounds CYP11B2, CYP11B1, CYP4B1 KDM4E 544/4885TYMS 466/4885HCAR2 1815/4885
US-20220009901-A1 CHEMICAL COMPOUNDS CYP11B2, CYP11B1, CYP4B1 KDM4E 544/4885TYMS 466/4885HCAR2 1815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.